All In MedTech

Device Trial Radar · NCT01110915

Advisa MRI Clinical Study

Advisa MRI™ System Clinical Investigation

Last checked: Nov 20, 2026Latest source record: Apr 30, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 269 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

269

Actual

Start

Jun 2010

Primary completion

Mar 2012

Study completion Mar 2013

Sponsor

Sponsor type
Industry
First posted
Apr 27, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Advisa MRI System clinical study is to confirm safety and effectiveness in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans up to 2W/kg Specific Absorption Rate (SAR) without positioning restrictions (MRI scans may occur anywhere on the body including the chest).

Conditions

  • Magnetic Resonance Imaging
  • Cardiac Pacemaker, Artificial

Interventions

  • Medtronic Advisa MRI Implantable Pulse Generator (IPG)Device

    Advisa MRI IPG is a dual chamber, multi-programmable IPG indicated to restore heart rates, improve cardiac output, prevent symptoms, or protect against arrhythmias related to cardiac impulse formation or conduction disorders. The IPG is indicated for use in patients who may benefit from rate-responsive pacing to support cardiac output during varying levels of activity and has been modified for use during an MRI exam.

  • Medtronic CapSureFix MRI™ active fixation MRI leadDevice

    The Medtronic CapSureFix MRI™ active fixation MRI lead is a transvenous, bipolar, silicone, steroid eluting and active fixation pacing lead. It is based on the commercially available Medtronic Model 5076 lead and has been modified for use in the MRI environment. The MRI lead is used for both atrial and ventricular applications.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Magnetic Resonance Imaging (MRI)-Related ComplicationsTime frame: MRI scan to one-month post-MRI scan
  2. Atrial Pacing Capture Threshold SuccessTime frame: Pre-MRI/waiting period to one month post-MRI/waiting period
  3. Ventricular Pacing Capture Threshold SuccessTime frame: Pre-MRI /waiting period to 1-month post-MRI/waiting period

Locations

37 sites in 13 countries. Site status is shown where the registry gives one.

  • Central Coast Cardiology

    Salinas, California

  • Mid Florida Cardiology

    Orlando, Florida

  • Iowa Heart Center

    West Des Moines, Iowa

34 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.